BioCentury
ARTICLE | Company News

Recordati, Merck KGaA sales and marketing update

January 3, 2011 8:00 AM UTC

Merck granted Recordati rights to market Cardicor bisoprolol in Italy. The beta blocker is marketed to treat heart failure associated with reduced systolic ventricular function. Further terms were not...